Source: India Infoline

SOVALDI: Natco files first Sovaldi ANDA

In 2017, Sovaldi reported $964mn revenue in global markets of which $130mn revenue came for the US.

Read full article »

SOVALDI's Competitors | SOVALDI's News | SOVALDI's Financials

Followers on Owler

1

Est. Annual Revenue

$5.0-25M

Est. Employees

25-100

CEO

Update CEO

CEO Approval Rating

- -/100

SOVALDI develops and commercializes drugs for hepatitis C treatment.